Search for Clinical Trial Results

Sponsored By

Autoimmune Hemolytic Anemia - 16 Studies Found

Status Study
Recruiting Study Name: A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA)
Condition: Warm Antibody Autoimmune Hemolytic Anemia
Date: 2015-11-19
Interventions: Drug: Fostamatinib 150 mg bid Fostamatinib 150 mg bid. The dose of Fostamatinib may be reduced at any ti
Recruiting Study Name: Immunopathology of Autoimmune Hemolytic Anemia
Condition: Autoimmune Hemolytic Anemia
Date: 2014-03-05
Interventions: Biological: blood samples
Recruiting Study Name: Study the Role of T Lymphocytes in Autoimmune Hemolytic Anemia
Condition: Autoimmune Hemolytic Anemia
Date: 2016-06-23
Interventions: Biological: blood sample
Active, not recruiting Study Name: Rituximab in Auto-Immune Hemolytic Anemia
Condition: Warm Autoimmune Hemolytic Anemia
Date: 2010-08-12
Interventions:
  • Drug: rituximab (Mabthera®)

Not yet recruiting Study Name: Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment
Condition: Autoimmune Hemolytic Anemia
Date: 2015-02-13
Interventions: Drug: Interleukine-2 Four courses of IL2 ( [Proleukin, Nov
Not yet recruiting Study Name: Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia.
Condition:
  • Anemia
  • Anemia, Hemolytic
  • Anemia, Hemolytic, Autoimmune Date: 2012-04-13
    Interventions:
    • Drug: levamisole

Completed Study Name: A Single-Arm Pilot Study With Low-Dose Rituximab Plus Standard Oral Prednisone In Idiopathic Autoimmune Hemolytic Anemia
Condition: Autoimmune Hemolytic Disease (Cold Type) (Warm Type)
Date: 2011-04-28
Interventions: Drug: prednisone, low dose rituximab Patients with "w
Not yet recruiting Study Name: A Safety Study of SYNT001 in Subjects With Chronic, Stable Warm Autoimmune Hemolytic Anemia (WAIHA)
Condition: Anemia, Hemolytic, Autoimmune
Date: 2017-03-03
Interventions: Drug: SYNT001 IV in 250 mL over 1 hour administered on Day 0, 7, 14, 21, and 28
Completed Study Name: Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease
Condition:
  • Cold Agglutinin Disease
  • Autoimmune Hemolytic Anemia

Date: 2016-02-16
Interventions: Drug: Bendamustine, Rituximab Bendamustine, Rituximab
Completed Study Name: Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT)
Condition: Chronic Lymphocytic Leukemia
Date: 2006-03-29
Interventions:
  • Biological: rituximab
  • Drug: cyclophosphami
Next >>>